| Literature DB >> 28192538 |
Bamini Gopinath1, Hanieh Moshtaghian2, Victoria M Flood3,4, Jimmy C Y Louie5,6, Gerald Liew1, George Burlutsky1, Paul Mitchell1.
Abstract
We aimed to investigate whether fish and long chain omega-3 polyunsaturated fatty acid (LCn-3 PUFA) consumption changed appreciably during adolescence. We also assessed whether these dietary variables are associated with retinal microvascular signs (possible markers of future cardiovascular disease risk). 633 children had dietary data at ages 12 and 17. Fish and LCn-3 PUFA [eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA)] intake was assessed by a food frequency questionnaire. Retinal vessel caliber was quantified from digital photographs using computer software. Mean energy-adjusted intakes (mg/day) of total LCn-3 PUFA, EPA, and DHA at age 12 were 297.1±261.1; 102.5±106.9; and 129.7±137.7, respectively; and this increased significantly at age 17 to: 347.0±324.0 (p<0.0001); 122.5±132.7 (p = 0.0001); and 160.3±171.4 (p <0.0001), respectively. Increasing quartiles of LCn-3PUFA intake were associated with widening of mean retinal arteriolar caliber among 17-year old girls ~3.9 μm (multivariable-adjusted P-trend = 0.001). Girls who consumed ≥2 serves of fish/week versus those who did not had ~2.1 μm wider retinal arterioles (p = 0.03). No associations were observed among boys or with retinal venules. Mean dietary intakes of LCn-3 PUFA increased during adolescence, but are still below recommended levels of consumption. These results suggest that LCn-3 PUFA and fish intake might have a beneficial influence.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28192538 PMCID: PMC5305252 DOI: 10.1371/journal.pone.0172109
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Baseline characteristics of 12- and 17-year old children (n = 633), stratified by gender.
| Characteristics | 12-year old | 17-year old | ||||
|---|---|---|---|---|---|---|
| Boys | Girls | P | Boys | Girls | P | |
| Age | 12.8 (0.4) | 12.7 (0.4) | 0.02 | 17.4 (0.5) | 17.2 (0.4) | <0.0001 |
| Ethnicity, % | ||||||
| Caucasian | 201 (71.3) | 212 (60.4) | 0.004 | 201 (71.3) | 212 (60.4) | 0.004 |
| East Asian | 34 (12.1) | 70 (19.9) | 0.01 | 34 (12.1) | 70 (19.9) | 0.01 |
| South Asian | 13 (4.6) | 18 (5.1) | 0.76 | 13 (4.6) | 18 (5.1) | 0.76 |
| Middle Eastern | 12 (4.3) | 22 (6.3) | 0.26 | 12 (4.3) | 22 (6.3) | 0.26 |
| Other | 22 (7.8) | 29 (8.3) | 0.26 | 22 (7.8) | 29 (8.3) | 0.26 |
| Parental education | 132 (50.4) | 154 (47.0) | 0.41 | 127 (52.7) | 151 (49.5) | 0.46 |
| Parental employment | 249 (95.4) | 298 (91.7) | 0.07 | 232 (95.6) | 288 (94.1) | 0.36 |
| BMI | 19.9 (3.9) | 20.2 (4.4) | 0.27 | 22.6 (4.1) | 22.4 (4.6) | 0.60 |
| MABP | 80.8 (7.6) | 81.5 (8.4) | 0.27 | 89.1 (8.7) | 84.4 (9.2) | <0.0001 |
| Axial length | 23.6 (0.8) | 23.1 (0.9) | <0.0001 | 23.6 (0.8) | 23.1 (0.9) | <0.0001 |
| Energy intake | 9330.9 (3642) | 8304.9 (3121) | 0.0002 | 9378.4 (3350) | 8084.0 (3008) | <0.0001 |
Data is presented as mean (SD) or n (%).
a Parents who had attained tertiary level education (greater than high school).
b Parents who were in full or part-time employment.
Energy-adjusted dietary intakes of long chain omega-3 polyunsaturated fatty acids (LCn-3 PUFA) at age 12 and 17 years among participants of the Sydney Childhood Eye Study during 2004–5 to 2009–11.
| LCn-3 PUFA (mg/ day) | 12 years | 17 years | Change in intake | |
|---|---|---|---|---|
| Mean (±SD) | Mean (±SD) | Mean (±SE) | ||
| All (n = 633) | ||||
| Total LCn-3PUFA | 297.1 (261.1) | 347.0 (324.0) | 49. (12.5) | <0.0001 |
| EPA | 102.5 (106.9) | 122.5 (132.7) | 19.9 (5.1) | 0.0001 |
| DPA | 63.4 (28.2) | 63.2 (28.6) | -0.2 (1.2) | 0.88 |
| DHA | 129.7 (137.7) | 160.3 (171.4) | 30.7 (6.6) | <0.0001 |
| Girls (n = 351) | ||||
| Total LCn-3PUFA | 309.0 (259.2) | 357.6 (318.1) | 48.6 (16.2) | 0.003 |
| EPA | 107.8 (105.6) | 127.1 (129.7) | 19.3 (6.5) | 0.004 |
| DPA | 65.2 (28.5) | 64.0 (28.3) | -1.1 (1.7) | 0.49 |
| DHA | 134.5 (137.0) | 165.5 (168.2) | 31.0 (8.5) | 0.0003 |
| Boys (n = 282) | ||||
| Total LCn-3PUFA | 282.4 (263.2) | 333.9 (331.2) | 57.4 (21.7) | 0.01 |
| EPA | 96.0 (108.2) | 116.7 (136.3) | 20.7 (8.1) | 0.01 |
| DPA | 61.2 (27.6) | 62.2 (29.0) | 1.0 (1.8) | 0.56 |
| DHA | 123.7 (138.5) | 153.9 (175.3) | 30.3 (10.3) | 0.003 |
Cross-sectional association between recommended intakes of fish consumption and EPA and DHA intakes and adjusted mean retinal vascular caliber in 12 year old participants.
| Retinal vascular caliber, mean (95% CI) | ||
|---|---|---|
| Dietary intake | Arteriolar caliber, μm | Venular caliber, μm |
| EPA + DHA ≥500 mg/day | ||
| No (n = 1741) | 151.1 (150.1–152.2) | 219.6 (218.2–221.1) |
| Yes (n = 179) | 151.2 (149.4–153.0) | 220.5 (217.9–223.1) |
| | 0.91 | 0.48 |
| Fish intake ≥2 serves/week | ||
| No (n = 1418) | 151.2 (150.1–152.4) | 219.6 (218.0–221.1) |
| Yes (n = 502) | 150.8 (149.5–152.2) | 220.1 (218.3–222.0) |
| | 0.51 | 0.51 |
| EPA + DHA ≥500 mg/day | ||
| No (n = 895) | 152.7 (151.5–153.9) | 221.3 (219.6–223.0) |
| Yes (n = 80) | 153.6 (151.0–156.3) | 223.8 (220.0–227.5) |
| | 0.47 | 0.19 |
| Fish intake ≥2 serves/week | ||
| No (n = 731) | 152.8 (151.5–154.0) | 221.6 (219.7–223.4) |
| Yes (n = 244) | 152.8 (151.1–154.4) | 221.5 (219.1–223.9) |
| | 1.00 | 0.96 |
| EPA + DHA ≥500 mg/day | ||
| No (n = 846) | 149.8 (148.5–151.2) | 217.5 (215.5–219.6) |
| Yes (n = 99) | 149.0 (146.7–151.4) | 217.4 (214.1–220.8) |
| | 0.49 | 0.95 |
| Fish intake ≥2 serves/week | ||
| No (n = 687) | 149.9 (148.5–151.4) | 217.2 (215.1–219.3) |
| Yes (n = 258) | 149.2 (147.4–150.9) | 218.3 (215.8–220.8) |
| | 0.35 | 0.32 |
aAustralian National Heart Foundation (ANHF) recommendation of two or more serves of oily fish per week and EPA and DHA intake of 500 mg/day or more [29].
b Adjusted for age, sex, ethnicity, energy intake, body mass index, mean arterial blood pressure, axial length, and fellow vessel caliber. Sex was not adjusted in the final model when analyzing boys and girls separately.
Cross-sectional association between recommended intakes of fish consumption and EPA and DHA intakes and adjusted mean retinal vascular caliber in 17-year old participants.
| Retinal vascular caliber, mean (95% CI) | ||
|---|---|---|
| Dietary intake | Arteriolar caliber, μm | Venular caliber, μm |
| EPA + DHA ≥500 mg/day | ||
| No (n = 1052) | 160.7 (160.1–161.3) | 233.0 (231.6–234.3) |
| Yes (n = 147) | 162.2 (160.6–163.9) | 232.0 (229.3–234.8) |
| | 0.09 | 0.50 |
| Fish intake ≥2 serves/week | ||
| No (n = 856) | 160.6 (159.9–161.3) | 232.9 (231.5–234.3) |
| Yes (n = 343) | 161.5 (160.4–162.6) | 232.8 (230.8–234.8) |
| | 0.20 | 0.93 |
| EPA + DHA ≥500 mg/day | ||
| No (n = 575) | 162.3 (161.0–163.6) | 237.8 (235.6–240.1) |
| Yes (n = 88) | 164.8 (162.4–167.1) | 235.9 (232.1–239.7) |
| | 0.04 | 0.29 |
| Fish intake ≥2 serves/week | ||
| No (n = 475) | 162.0 (160.6–163.4) | 238.3 (236.0–240.7) |
| Yes (n = 188) | 164.1 (162.3–165.9) | 235.7 (232.8–238.6) |
| | 0.03 | 0.07 |
| EPA + DHA ≥500 mg/day | ||
| No (n = 477) | 158.8 (157.3–160.1) | 234.5 (232.1–236.8) |
| Yes (n = 59) | 159.1 (156.5–161.7) | 233.5 (229.5–237.6) |
| | 0.80 | 0.64 |
| Fish intake ≥2 serves/week | ||
| No (n = 381) | 159.0 (157.5–160.5) | 234.5 (232.0–236.9) |
| Yes (n = 155) | 158.4 (156.6–160.2) | 234.1 (231.3–237.0) |
| | 0.51 | 0.82 |
aAustralian National Heart Foundation (ANHF) recommendation of two or more serves of oily fish per week and EPA and DHA intake of 500 mg/day or more [29].
bAdjusted for age, sex, ethnicity, energy intake, body mass index, mean arterial blood pressure, axial length, and fellow vessel caliber. Sex was not adjusted in the final model when analyzing boys and girls separately.
Association between quartiles of long chain omega-3 polyunsaturated fatty acids (LCn-3 PUFA) and adjusted mean retinal vascular caliber in 17-year old girls.
| Retinal vessel caliber (μm), mean (95% CI) | ||
|---|---|---|
| Dietary intake (mg/ day) | Arteriolar caliber | Venular caliber |
| Total LCn-3PUFA | ||
| 1st quartile (≤116.2), n = 165 | 160.9 (159.2–162.5) | 234.2 (231.4–237.0) |
| 2nd quartile (116.3–255.3), n = 166 | 161.6 (159.9–163.4) | 235.1 (232.1–238.0) |
| 3rd quartile (255.5–438.1), n = 166 | 162.1 (160.6–163.7) | 236.5 (233.9–239.2) |
| 4th quartile (≥443.1), n = 166 | 164.8 (163.2–166.4) | 231.8 (229.0–234.7) |
| | 0.001 | 0.10 |
| EPA | ||
| 1st quartile (≤34.7), n = 165 | 160.6 (158.9–162.2) | 234.8 (232.0–237.7) |
| 2nd quartile (34.7–88.4), n = 166 | 161.9 (160.3–163.6) | 234.8 (231.9–237.7) |
| 3rd quartile (88.4–166.2), n = 166 | 162.4 (160.9–164.0) | 236.3 (233.5–239.1) |
| 4th quartile (≥166.9), n = 166 | 164.3 (162.8–165.9) | 231.9 (229.2–234.7) |
| | 0.0004 | 0.05 |
| DPA | ||
| 1st quartile (≤33.6), n = 165 | 160.5 (158.8–162.1) | 236.0 (233.1–238.9) |
| 2nd quartile (33.8–53.5), n = 166 | 163.0 (161.3–164.6) | 233.4 (230.6–236.3) |
| 3rd quartile (53.6–78.8), n = 166 | 162.9 (161.2–164.5) | 234.0 (231.1–236.8) |
| 4th quartile (≥79.0), n = 166 | 163.6 (161.7–165.4) | 234.0 (230.8–237.2) |
| | 0.08 | 0.39 |
| DHA | ||
| 1st quartile (≤37.4), n = 165 | 161.2 (159.6–162.8) | 234.2 (231.5–236.9) |
| 2nd quartile (37.7–116.7), n = 166 | 161.8 (160.0–163.6) | 235.0 (232.0–238.0) |
| 3rd quartile (116.9–205.0), n = 166 | 162.0 (160.5–163.6) | 236.5 (233.8–239.1) |
| 4th quartile (≥206.3), n = 166 | 164.5 (162.8–166.1) | 231.9 (229.1–234.7) |
| | 0.003 | 0.16 |
aValues are adjusted means; 95% CIs in parentheses. Values were calculated by using ANCOVA and were adjusted for age, ethnicity, energy intake, body mass index, mean arterial blood pressure, axial length, and fellow vessel caliber.
Association between quartiles of long chain omega-3 polyunsaturated fatty acids (LCn-3 PUFA) and adjusted mean retinal vascular caliber in 17-year old boys.
| Retinal vessel caliber (μm), mean (95% CI) | ||
|---|---|---|
| Dietary intake | Arteriolar caliber | Venular caliber |
| Total LCn-3PUFA | ||
| 1st quartile (≤128.9), n = 134 | 159.3 (157.6–160.7) | 229.9 (226.9–232.8) |
| 2nd quartile (128.9–231.2), n = 134 | 159.1 (157.7–161.5) | 230.6 (227.9–233.3) |
| 3rd quartile (232.6–416.2), n = 134 | 158.9 (157.3–160.5) | 232.3 (229.5–235.1) |
| 4th quartile (≥417.3), n = 134 | 158.6 (156.9–160.2) | 231.7 (228.9–234.6) |
| | 0.63 | 0.46 |
| EPA | ||
| 1st quartile (≤35.6), n = 134 | 158.8 (157.2–160.5) | 229.9 (226.9–232.8) |
| 2nd quartile (36.1–74.1), n = 134 | 158.9 (157.4–160.3) | 232.0 (229.3–234.7) |
| 3rd quartile (75.8–131.6), n = 134 | 159.7 (158.1–161.3) | 231.1 (228.3–233.9) |
| 4th quartile (≥131.9), n = 134 | 158.5 (156.8–160.2) | 231.6 (228.6–234.6) |
| | 0.44 | 0.32 |
| DPA | ||
| 1st quartile (≤40.1), n = 134 | 159.0 (157.1–160.9) | 232.2 (229.0–235.4) |
| 2nd quartile (40.4–58.3), n = 134 | 158.5 (156.9–160.0) | 231.8 (229.0–234.6) |
| 3rd quartile (58.4–82.1), n = 134 | 159.7 (158.1–161.3) | 228.5 (225.7–231.2) |
| 4th quartile (≥82.1), n = 134 | 158.8 (157.1–160.6) | 232.1 (229.1–235.0) |
| | 0.90 | 0.77 |
| DHA | ||
| 1st quartile (≤45.1), n = 134 | 159.0 (157.3–160.7) | 229.8 (226.8–232.8) |
| 2nd quartile (45.2–98.1), n = 134 | 159.0 (157.6–160.4) | 232.0 (229.4–234.7) |
| 3rd quartile (99.1–196.7), n = 134 | 158.7 (157.1–160.4) | 230.9 (228.0–233.8) |
| 4th quartile (≥196.8), n = 134 | 159.2 (157.6–160.8) | 231.6 (228.7–234.5) |
| | 0.84 | 0.67 |
aValues are adjusted means; 95% CIs in parentheses. Values were calculated by using ANCOVA and were adjusted for age, ethnicity, energy intake, body mass index, mean arterial blood pressure, axial length, and fellow vessel caliber.